ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DXST vs TMO // FREE CASH FLOW YIELD

Decent Holding Inc (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DXST 1 — TMO 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DXST VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DXST TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 26.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — 2.40% — TIE /fcf-yield <GO>
Operating Margin -1.10% 17.40% -18.50 TMO /operating-margins <GO>
Net Profit Margin -2.50% 15.10% -17.60 TMO /net-margins <GO>
Revenue Growth (YoY) 12.20% 3.90% +8.30 DXST /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.1 62.9 -28.80 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.4M $262.22B -$262.21B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DXST REV TMO REV DXST GROSS % TMO GROSS % DXST FCF TMO FCF
FY 2025 $12.9M $44.56B 26.2% — -$3.5M $6.29B
FY 2024 $11.5M $42.88B 27.8% — -$440.5K $7.27B
FY 2023 $9.4M $42.86B — — $1.6M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DXST // BETA —
TMO // BETA 0.94